Determinants of progression of aortic valve stenosis and outcome of adverse events in hemodialysis patients

Journal of Cardiology

Volumn 59, Issue 1, 2012, Pages 78-83

  Hoshina, Mizuho ^a   Wada, Hiroshi ^a   Sakakura, Kenichi ^a   Kubo, Norifumi ^a   Ikeda, Nahoko ^a   Sugawara, Yoshitaka ^a   Yasu, Takanori ^b   Ako, Junya ^a   Momomura, Shin ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Aortic valve stenosis; Calcium; Hemodialysis

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM PHOSPHATE; COLECALCIFEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE; TRIACYLGLYCEROL;

ADVERSE OUTCOME; AGED; AORTA VALVE STENOSIS; ARTICLE; BICUSPID AORTIC VALVE; BIOCHEMISTRY; CALCIUM ANTAGONISM; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC NEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE AORTIC VALVE STENOSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG USE; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE PRESSURE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERTENSIVE NEPHROPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PEAK PRESSURE GRADIENT; PHYSICAL EXAMINATION; PREDICTOR VARIABLE; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; AORTIC VALVE STENOSIS; BLOOD PRESSURE; CALCIUM; CALCIUM PHOSPHATES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84855190101     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.10.003     Document Type: Article

References (21)

1. Perkovic V., Hunt D., Griffin S.V., du Plessis M., Becker G.J. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract 2003, 94:c40-c45.
2. Du X., Soon J.L. Mild to moderate aortic stenosis and coronary bypass surgery. J Cardiol 2011, 57:31-35.
3. Cowell S.J., Newby D.E., Prescott R.J., Bloomfield P., Reid J., Northridge D.B., Boon N.A., Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005, 352:2389-2397.
4. Rossebo A.B., Pedersen T.R., Boman K., Brudi P., Chambers J.B., Egstrup K., Gerdts E., Gohlke-Bärwolf C., Holme I., Kesäniemi Y.A., Malbecq W., Nienaber C.A., Ray S., Skjaerpe T., Wachtell K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008, 359:1343-1356.
5. Mahajan N., Khetarpal V., Afonso L. Stroke secondary to calcific bicuspid aortic valve: case report and literature review. J Cardiol 2009, 54:158-161.
6. Roger V.L., Tajik A.J., Bailey K.R., Oh J.K., Taylor C.L., Seward J.B. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 1990, 119(2 Pt. 1):331-338.
7. Otto C.M., Burwash I.G., Legget M.E., Munt B.I., Fujioka M., Healy N.L., Kraft C.D., Miyake-Hull C.Y., Schwaegler R.G. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997, 95:2262-2270.
8. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D.W., Otto C.M. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630-634.
9. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., Siscovick D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999, 341:142-147.
10. Waters D.D. Exploring new indications for statins beyond atherosclerosis: successes and setbacks. J Cardiol 2010, 55:155-162.
11. Katz R., Wong N.D., Kronmal R., Takasu J., Shavelle D.M., Probstfield J.L., Bertoni A.G., Budoff M.J., O'Brien K.D. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 2006, 113:2113-2119.
12. Petrovic D., Obrenovic R., Stojimirovic B. Risk factors for aortic valve calcification in patients on regular hemodialysis. Int J Artif Organs 2009, 32:173-179.
13. Onufrak S.J., Bellasi A., Shaw L.J., Herzog C.A., Cardarelli F., Wilson P.W., Vaccarino V., Raggi P. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 2008, 199:424-431.
14. Lind L., Skarfors E., Berglund L., Lithell H., Ljunghall S. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997, 50:967-973.
15. Larsson T.E., Olauson H., Hagstrom E., Ingelsson E., Arnlöv J., Lind L., Sundström J. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol 2010, 30:333-339.
16. Kovesdy C.P., Kuchmak O., Lu J.L., Kalantar-Zadeh K. Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:468-476.
17. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
18. Owens D.S., Otto C.M. Is it time for a new paradigm in calcific aortic valve disease?. JACC Cardiovasc Imaging 2009, 2:928-930.
19. Paramsothy P., Katz R., Owens D.S., Burke G.L., Probstfield J.L., O'Brien K.D. Age-modification of lipoprotein, lipid, and lipoprotein ratio-associated risk for coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2010, 105:352-358.
20. Novaro G.M., Katz R., Aviles R.J., Gottdiener J.S., Cushman M., Psaty B.M., Otto C.M., Griffin B.P. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007, 50:1992-1998.
21. Goodkin D.A. An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Apher Dial 2005, 9:431-458.